Text Size
59 studies found for:    "Fanconi renotubular syndrome"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Unknown † Cure Cystinosis International Registry
Conditions: Cystinosis;   Nephropathic Cystinosis;   Renal Fanconi Syndrome
Intervention:
2 Completed Fanconi Syndrome Due to ARVs in HIV-Infected Persons
Conditions: HIV Infections;   Fanconi Syndrome;   Kidney Disease;   Renal Impairment
Intervention: Procedure: Blood Draws
3 Completed Evaluation of Fanconi Syndrome and Cystinosis
Conditions: Cystinosis;   Fanconi Syndrome
Intervention:
4 Completed Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias
Conditions: Beta-thalassemia;   Myelodysplastic Syndromes;   Fanconi Syndrome;   Anemia, Diamond-Blackfan;   Anemia, Aplastic
Intervention: Drug: Deferasirox
5 Completed The Role of Susceptibility to Thrombosis in the Pseudotumor Cerebri of Nephropathic Cystinosis: A Case-Control Study
Conditions: Pseudotumor Cerebri;   Cystinosis
Intervention:
6 Completed Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™
Conditions: Cystinosis;   Nephropathic Cystinosis
Intervention: Drug: Cysteamine bitartrate
7 Completed Phase 3 Study of Cysteamine Bitartrate Delayed-release (RP103) Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate);   Drug: Cysteamine Bitartrate Delayed-release Capsules (RP103)
8 Completed Pilot Study of Safety, Tolerability, Pharmacokinetics/Pharmacodynamics (PK/PD) of RP103 Compared to Cystagon® in Patients With Cystinosis
Condition: Cystinosis
Interventions: Drug: Cystagon® (Cysteamine Bitartrate) Capsules: 150 mg/50 mg;   Drug: RP103
9 Completed Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
Condition: Cystinosis
Intervention:
10 Active, not recruiting Kidney Transplantation in Patients With Cystinosis
Condition: Cystinosis
Intervention:
11 Completed Cord Blood Stem Cell Transplantation Study (COBLT)
Conditions: Anemia, Aplastic;   Fanconi Anemia;   Hematologic Diseases;   Leukemia;   Neoplasms;   Severe Combined Immunodeficiency;   Hematopoietic Stem Cell Transplantation;   Myelodysplastic Syndromes
Intervention: Procedure: stem cell transplantation
12 Terminated
Has Results 		Stem Cell Transplantation for Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Procedure: Hematopoietic Stem Cell Transplant;   Procedure: Thymic Shielding During Radiation;   Procedure: Total Body Irradiation;   Drug: Cyclophosphamide, Fludarabine
13 Completed Busulfan, Antithymocyte Globulin, and Fludarabine Followed By a Donor Stem Cell Transplant in Treating Young Patients With Blood Disorders, Bone Marrow Disorders, Chronic Myelogenous Leukemia in First Chronic Phase, or Acute Myeloid Leukemia in First Remission
Conditions: Congenital Amegakaryocytic Thrombocytopenia;   Diamond-blackfan Anemia;   Fanconi Anemia;   Leukemia;   Severe Congenital Neutropenia;   Thrombocytopenia
Interventions: Biological: anti-thymocyte globulin;   Drug: busulfan;   Drug: fludarabine phosphate;   Procedure: allogeneic bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: umbilical cord blood transplantation;   Radiation: radiation therapy
14 Unknown † Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia
Conditions: Fanconi Anemia;   Leukemia;   Myelodysplastic Syndromes
Interventions: Genetic: western blotting;   Other: laboratory biomarker analysis
15 Completed Mobilization and Collection of Peripheral Blood Stem Cells in Patients With Fanconi Anemia Using G-CSF and AMD3100
Condition: Fanconi Anemia
Interventions: Drug: AMD3100;   Device: AmCell CliniMACs
16 Unknown † Fanconi Anemia Transplant Lacking Genotypically Identical Donor
Condition: Fanconi Anemia
Intervention: Device: Miltenyi CliniMACs device
17 Recruiting Gene Therapy for Fanconi Anemia
Condition: Fanconi Anemia
Interventions: Biological: filgrastim;   Drug: plerixafor;   Procedure: leukapheresis;   Biological: genetically engineered lymphocyte therapy;   Other: laboratory biomarker analysis;   Genetic: polymerase chain reaction
18 Active, not recruiting Tissue Sample Collection From Patients With Fanconi Anemia
Conditions: Fanconi Anemia;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Other: biologic sample preservation procedure;   Procedure: biopsy
19 Completed Collection of Blood and Bone Marrow From Healthy Volunteers and Patients for Research Purposes
Conditions: Aplastic Anemia;   Fanconi's Anemia;   Healthy;   Hematologic Disease;   Myelodysplastic Syndrome
Intervention:
20 Unknown † Phase I Study of Amifostine in Patients With Bone Marrow Failure Related to Fanconi's Anemia
Condition: Fanconi's Anemia
Intervention: Drug: amifostine
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years